Clinical Trial Update: Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine [Phase 4]

View source ↗

Summary

Phase 4 trial update on safety, immunogenicity, and immune persistence of an inactivated Hepatitis A vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Hepatitis A vaccine (inactivated, Sinovac)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hepatitis A | Phase 4 | Status: COMPLETED